curcumin – a promising phytocompound of immense potential

Curcumin is a polyphenol derived from the curcuma longa plant (diferuloylmethane). for thousands of years it has been employed in ayurvedic medicine for a range of therapeutic features, including relief of pain, reactive oxygen activity, inflammatory prevention and antibacterial qualities. curcumin activity is displayed in the cell through a clustering of signaling pathways at different stages. curcumin's anticancer capabilities have recently been examined in a number of ways, including expression of cancer gene, cancer spread, cell cycle control and regulation, scheduled death of cells and malignancy development. curcumin's enormous promise as a cancer treatment has been demonstrated in all of such studies. it has many applications in the fight against cardiovascular, reactive oxygen, microbial and fungal diseases. curcumin nano-formulations are also investigated for its impact on cancer and therapeutic advantages. the current review summarizes the investigations done as well as data supporting the pharmacological activity of curcumin.